Literature DB >> 16738222

Negative regulation of superoxide dismutase-1 promoter by thyroid hormone.

Guilherme M Santos1, Valéry Afonso, Gustavo B Barra, Marie Togashi, Paul Webb, Francisco A R Neves, Noureddine Lomri, Abderrahim Lomri.   

Abstract

The role of thyroid hormone [L-3,5,3'-triiodothyronine (T3)] and the thyroid hormone receptor (TR) in regulating growth, development, and metabolic homeostasis is well established. It is also emerging that T3 is associated with oxidative stress through the regulation of the activity of superoxide dismutase-1 (SOD-1), a key enzyme in the metabolism of oxygen free radicals. We found that T3 reverses the activation of the SOD-1 promoter caused by the free radical generators paraquat and phorbol 12-myristate 13-acetate through the direct repression of the SOD-1 promoter by liganded TR. Conversely, the SOD-1 promoter is significantly stimulated by unliganded TRs. This regulation requires the DNA-binding domain of the TR, which is recruited to an inhibitory element between -157 and +17 of the SOD-1 promoter. TR mutations, which abolish recruitment of coactivator proteins, block repression of the SOD-1 promoter. Conversely, a mutation that inhibits corepressor binding to the TR prevents activation. Together, our findings suggest a mechanism of negative regulation in which TR binds to the SOD-1 promoter but coactivator and corepressor binding surfaces have an inverted function. This effect may be important in T3 induction of oxidative stress in thyroid hormone excess.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16738222     DOI: 10.1124/mol.106.025627

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  15 in total

1.  M-protein is down-regulated in cardiac hypertrophy driven by thyroid hormone in rats.

Authors:  Andrei Rozanski; Ana Paula C Takano; Patricia N Kato; Antonio G Soares; Camilo Lellis-Santos; Juliane Cruz Campos; Julio Cesar Batista Ferreira; Maria Luiza M Barreto-Chaves; Anselmo S Moriscot
Journal:  Mol Endocrinol       Date:  2013-10-31

2.  Effects of Dendropanax morbifera Léveille extract on hypothyroidism-induced oxidative stress in the rat hippocampus.

Authors:  Dae Young Yoo; Hyo Young Jung; Hyun Jung Kwon; Jong Whi Kim; Sung Min Nam; Jin Young Chung; Jung Hoon Choi; Dae Won Kim; Yeo Sung Yoon; In Koo Hwang
Journal:  Food Sci Biotechnol       Date:  2016-12-31       Impact factor: 2.391

3.  Nuclear corepressors mediate the repression of phospholipase A2 group IIa gene transcription by thyroid hormone.

Authors:  Pragya Sharma; Shalini Thakran; Xiong Deng; Marshall B Elam; Edwards A Park
Journal:  J Biol Chem       Date:  2013-04-29       Impact factor: 5.157

Review 4.  Thyroid hormone receptors and resistance to thyroid hormone disorders.

Authors:  Tânia M Ortiga-Carvalho; Aniket R Sidhaye; Fredric E Wondisford
Journal:  Nat Rev Endocrinol       Date:  2014-08-19       Impact factor: 43.330

5.  SOD1 Transcriptional and Posttranscriptional Regulation and Its Potential Implications in ALS.

Authors:  Pamela Milani; Stella Gagliardi; Emanuela Cova; Cristina Cereda
Journal:  Neurol Res Int       Date:  2011-04-17

Review 6.  Negative regulation by nuclear receptors: a plethora of mechanisms.

Authors:  Guilherme M Santos; Louise Fairall; John W R Schwabe
Journal:  Trends Endocrinol Metab       Date:  2010-12-31       Impact factor: 12.015

7.  3, 3'5 Triiodo L thyronine induces apoptosis in human breast cancer MCF-7 cells, repressing SMP30 expression through negative thyroid response elements.

Authors:  Pranati Sar; Rosalima Peter; Bandita Rath; Alok Das Mohapatra; Sandip K Mishra
Journal:  PLoS One       Date:  2011-06-07       Impact factor: 3.240

8.  Liganded thyroid hormone receptor inhibits phorbol 12-O-tetradecanoate-13-acetate-induced enhancer activity via firefly luciferase cDNA.

Authors:  Hiroko Misawa; Shigekazu Sasaki; Akio Matsushita; Kenji Ohba; Hiroyuki Iwaki; Hideyuki Matsunaga; Shingo Suzuki; Keiko Ishizuka; Yutaka Oki; Hirotoshi Nakamura
Journal:  PLoS One       Date:  2012-01-13       Impact factor: 3.240

9.  Effect of leucovorin (folinic acid) on the developmental quotient of children with Down's syndrome (trisomy 21) and influence of thyroid status.

Authors:  Henri Blehaut; Clotilde Mircher; Aimé Ravel; Martine Conte; Veronique de Portzamparc; Gwendael Poret; Françoise Huon de Kermadec; Marie-Odile Rethore; Franck G Sturtz
Journal:  PLoS One       Date:  2010-01-11       Impact factor: 3.240

10.  To bind or not to bind - how to down-regulate target genes by liganded thyroid hormone receptor?

Authors:  Joachim M Weitzel
Journal:  Thyroid Res       Date:  2008-10-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.